All > Adhd > Sacramento
Behavioural Intervention

ADHD Therapy for Attention Deficit Hyperactivity Disorder (ADHD)

FutureSearch Trials of Dallas, Dallas, TX
ADHD Therapy +1 moreN/ARecruitingLed by Ann Childress, MDResearch Sponsored by Lumos Labs, Inc.

Study Summary

This trial will test a new digital therapy for treating adults with ADHD. The therapy will be delivered through a game, and the goal is to see if it is safe and effective.

Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below
Select...
You have a baseline score of 28 or higher on the clinician-rated ADHD-RS total score.
Select...
Your ADHD symptoms, as evaluated by a doctor, have a score of 28 or higher on a specific scale.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at study day 63
This trial's timeline: 3 weeks for screening, Varies for treatment, and at study day 63 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Test of Variables of Attention (TOVA®) Attention Comparison Score (ACS)
Secondary outcome measures
ADHD-RS-5 Inattention Subscale with Adult Prompts
Behavior Rating Inventory of Executive Function - Adult Version (BRIEF-A) Working Memory and Inhibit Percentiles
Cambridge Brain Sciences Spatial Span
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ADHD TherapyExperimental Treatment1 Intervention
Group II: Control TherapyActive Control1 Intervention

Find a site

Who is running the clinical trial?

Lumos Labs, Inc.Lead Sponsor
13 Previous Clinical Trials
15,636 Total Patients Enrolled
1 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
194 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
Ann Childress, MDPrincipal Investigator
Clinical Research of Southern Nevada, LLC
10 Previous Clinical Trials
1,533 Total Patients Enrolled
10 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
1,533 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)

Media Library

ADHD Therapy (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05296473 — N/A
Attention Deficit Hyperactivity Disorder (ADHD) Research Study Groups: ADHD Therapy, Control Therapy
Attention Deficit Hyperactivity Disorder (ADHD) Clinical Trial 2023: ADHD Therapy Highlights & Side Effects. Trial Name: NCT05296473 — N/A
ADHD Therapy (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05296473 — N/A
Attention Deficit Hyperactivity Disorder (ADHD) Patient Testimony for trial: Trial Name: NCT05296473 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies within this clinical trial?

"This clinical trial, which was initially advertised on May 5th 2022, is currently recruiting participants. The details of the study were last updated September 30th 2022 according to data hosted by clinicaltrials.gov."

Answered by AI

Does this trial include elderly participants aged 80 or more?

"Admittance to this trial is limited to individuals between 22 and 55 years of age."

Answered by AI

Who meets the criteria for enrollment in this clinical trial?

"To join this clinical trial, patients must have a confirmed diagnosis of Attention Deficit Hyperactivity Disorder (ADHD) and be between the ages of 22-55. A total of 472 participants are being recruited for the study."

Answered by AI

How many volunteers are engaged in this research project?

"In order to complete the trial, Lumos Labs Inc. needs 472 participants that fulfill its inclusion criteria. The study will be conducted in two sites: UC Davis MIND Institute in Sacramento and FutureSearch Trials of Dallas in Texas."

Answered by AI

How many locations are implementing this research endeavor?

"At present, 10 sites are running this trial. These include Sacramento, Dallas and Lincoln as well as other cities nearby. When considering enrollment in the study, it is recommended to pick a location that has minimal travel requirements for you personally."

Answered by AI

Who else is applying?

What state do they live in?
Nevada
California
Texas
Other
How old are they?
18 - 65
What site did they apply to?
Melmed Center
Center of Psychiatry and Behavioral Medicine
FutureSearch Trials of Dallas
Other
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
1
3+
2
0

Why did patients apply to this trial?

are these paid studies? Address medical condition. Tired of letting adhd rule my life.
Patient
Interested in finding the best treatment with results. I have been prescribed many drugs without a good match.
Patient

What questions have other patients asked about this trial?

What are the benefits? Can this be done virtually? How long do screenings take?
Patient
How will the process go about? Anything closer to Raleigh, NC?
Patient

How responsive is this trial?

Most responsive sites:
  1. Alivation Research, LLC: < 24 hours
  2. Center of Psychiatry and Behavioral Medicine: < 24 hours
  3. FutureSearch Trials of Dallas: < 48 hours
Average response time
  • < 2 Days
Typically responds via
Phone Call
Email
Recent research and studies
clinicaltrials.govStudy
Guided ADHD Therapy for Managing the Extent and Severity of Symptoms
2022. "Guided ADHD Therapy for Managing the Extent and Severity of Symptoms". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05296473.
~202 spots leftby Oct 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top